CompletedNot Applicable

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

United States107 participantsStarted 2016-02-15

Plain-language summary

To evaluate whether formal referral to The Symptom Management and Supportive Care Clinic improves symptom burden in advanced stage or recurrent gynecologic oncology chemotherapy patients compared with symptom management performed by the primary gynecologic oncologist.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female * 18 years of age or older * Diagnosis of Stage III, IV, or recurrent gynecologic malignancy (Uterine, Ovarian, Cervical, Vulvar, Vaginal, Fallopian Tube, Primary Peritoneal) * Receiving active intravenous, intraperitoneal, or oral chemotherapy * Patient at University of Michigan Gynecologic Oncology Clinic Exclusion Criteria: * Male * Less than 18 years of age * Patients without a diagnosis of a gynecologic malignancy * Patients not receiving intravenous, intraperitoneal or oral chemotherapy at the time of enrollment * Patients receiving radiation therapy with chemo-sensitization.

What they're measuring

Change in Patient-Reported Symptom Burden as Determined by the Edmonton Symptom Assessment System

Timeframe: Baseline and 3 months after study start

Change in Patient-Reported Symptom Burden as Determined by the National Comprehensive Cancer Network Distress Screening Tool

Timeframe: Baseline and 3 months after study start

Trial details

NCT IDNCT02786524

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10-31

View on ClinicalTrials.gov More Uterine Cervical Neoplasms trials